Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute for the Study, Research and Education in Diabetes Mellitus and Metabolic Diseases (IEDM) is a specialized clinical research organization and medical center based in Mexico City. It serves as a premier site for international multicenter clinical trials, focusing primarily on Phase 2, 3, and 4 studies in the fields of endocrinology and metabolism. IEDM provides comprehensive services including clinical trial management, specialized patient care for metabolic disorders, and professional medical education for healthcare providers. The institute is recognized for its high recruitment capacity and its long-standing collaborations with global pharmaceutical leaders to evaluate novel therapies for diabetes and obesity. By integrating clinical practice with rigorous scientific research, IEDM plays a significant role in advancing metabolic health standards in Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for the Study, Research and Education in Diabetes Mellitus and Metabol.